FBX14 Antibody

Shipped with Ice Packs
In Stock

Description

Introduction to FBX14 Antibody

The FBX14 antibody is a tool used in immunodetection for the protein F-box and leucine-rich repeat protein 14 (FBXL14). This protein is involved in various cellular processes and is widely expressed across different tissue types. The FBXL14 protein itself is a member of the F-box family, which plays a role in the ubiquitin-proteasome pathway, crucial for protein degradation and cellular regulation.

Characteristics of FBX14 Antibody

FBX14 antibodies are designed to target the FBXL14 protein, which has a reported length of 418 amino acid residues and a mass of approximately 45.9 kDa. These antibodies are commonly used in research applications such as Western Blotting (WB), Enzyme-Linked Immunosorbent Assay (ELISA), and Immunohistochemistry (IHC). They are available in various forms, including unconjugated and conjugated versions, depending on the specific application requirements.

Table 1: Applications and Reactivity of FBX14 Antibodies

ApplicationReactivityConjugate/Tag
Western Blot (WB)Human, Mouse, RatUnconjugated
Enzyme-Linked Immunosorbent Assay (ELISA)Human, Mouse, RatUnconjugated
Immunohistochemistry (IHC)Human, Mouse, RatUnconjugated

Research Findings and Uses

FBXL14 antibodies are utilized in studying the role of FBXL14 in cellular processes. The protein is known for its involvement in the regulation of various biological pathways, and its expression is observed in multiple tissue types. In research settings, these antibodies help in understanding the protein's function and its potential implications in disease models.

Table 2: Suppliers and Products

SupplierProduct DescriptionPrice
Fine Biotech Co., Ltd.FBXL14 antibody, unconjugated$240.00
GeneTexAnti-FBXL14 antibody, unconjugated$399.00
United States BiologicalRabbit Anti-FBXL14, CT Antibody, unconjugated$529.00

References

- Biocompare. (2008). Anti-FBXL14 Antibody Products.
- Biocompare. (2008). FBXL14 Antibody Products.
- PMC. (2011). Development of an Fn14 agonistic antibody as an anti-tumor agent. (Note: While this reference does not directly relate to FBX14, it provides context on the broader use of antibodies in research and therapy.)

Product Specs

Buffer
Preservative: 0.03% Proclin 300. Constituents: 50% Glycerol, 0.01M PBS, pH 7.4.
Form
Liquid
Lead Time
14-16 weeks (Made-to-order)
Synonyms
FBX14 antibody; At4g24390 antibody; T22A6.220F-box protein FBX14 antibody; Transport inhibitor response 1-like protein antibody; TIR1-like protein antibody
Target Names
FBX14
Uniprot No.

Target Background

Gene References Into Functions
The following publications support the relevance of the target to its functions: 1. Arabidopsis afb4/5 mutants exhibit phenotypes similar to rms2, including increased shoot branching, reduced expression of strigolactone (SL) biosynthesis genes, and elevated auxin levels in stems. (PMID: 29220348) 2. Complete loss-of-function of the AFB4 gene results in defects across multiple aspects of the plant life cycle, including lateral root development and hypocotyl elongation, and altered responses to specific phytopathogens. (PMID: 22357482)
Database Links

KEGG: ath:AT4G24390

STRING: 3702.AT4G24390.1

UniGene: At.32351

Subcellular Location
Nucleus.

Q&A

What is FBX14 protein and why is it important in plant research?

FBX14 is an F-box protein found in Arabidopsis thaliana (Mouse-ear cress) that plays a role in plant protein degradation pathways through the ubiquitin-proteasome system. F-box proteins generally function as part of SCF (Skp1-Cullin-F-box) complexes that target specific proteins for ubiquitination and subsequent degradation. In plants, F-box proteins are particularly numerous and diverse, with Arabidopsis containing over 700 F-box genes, suggesting their importance in plant-specific biological processes. FBX14 specifically may be involved in plant development, stress responses, or hormone signaling pathways, making it a valuable target for researchers studying plant molecular biology. Understanding FBX14 function can provide insights into plant regulatory mechanisms and potentially inform agricultural applications.

What types of FBX14 antibodies are available for research?

Based on the available information, there is a polyclonal FBX14 antibody (CSB-PA840425XA01DOA) produced using recombinant Arabidopsis thaliana FBX14 protein as the immunogen and raised in rabbits . This antibody has been tested for applications including ELISA and Western blot, specifically for detecting FBX14 in Arabidopsis thaliana samples . The antibody is provided in liquid form, stored in a buffer containing 50% glycerol, 0.01M PBS (pH 7.4), and 0.03% Proclin 300 as a preservative . This polyclonal antibody has been affinity-purified against the antigen to enhance specificity for experimental applications. While specific information about other FBX14 antibodies is limited in the current literature, researchers should verify current options when planning experiments to ensure availability of appropriate tools for their specific research needs.

How should FBX14 antibody be stored and handled to maintain effectiveness?

According to the product information, FBX14 antibody should be stored at -20°C or -80°C upon receipt to maintain its stability and effectiveness . Researchers should avoid repeated freeze-thaw cycles as these can degrade antibody quality and reduce binding efficiency over time. When working with the antibody, it should be kept on ice or at 4°C during experiments to minimize degradation. For long-term storage planning, it's advisable to aliquot the antibody into smaller volumes upon receipt to minimize the number of freeze-thaw cycles. The antibody is formulated in a buffer containing glycerol (50%), which helps prevent complete freezing and reduces damage during storage . Always ensure proper labeling of antibody aliquots with relevant information including date of receipt, lot number, and dilution information to maintain experimental reproducibility.

What are the optimal protocols for using FBX14 antibody in Western blotting?

For Western blotting applications with FBX14 antibody, researchers should begin with sample preparation by extracting proteins from Arabidopsis thaliana tissues using an appropriate lysis buffer that preserves protein integrity. Based on general antibody protocols, a recommended dilution range would be 1:500 to 1:2000 for primary antibody incubation, though optimization may be necessary for specific experimental conditions. Blocking should be performed with 5% non-fat dry milk or bovine serum albumin (BSA) in TBST to minimize background signals. Incubation with the primary antibody (FBX14) should be conducted overnight at 4°C with gentle agitation to ensure optimal binding. Following primary antibody incubation, membranes should be washed thoroughly with TBST (at least 3 washes of 5-10 minutes each) before adding an appropriate HRP-conjugated secondary antibody (anti-rabbit IgG) at a dilution of approximately 1:5000 to 1:10000. Signal detection can be performed using enhanced chemiluminescence (ECL) reagents, with exposure times determined empirically based on signal strength.

Table 1: Recommended Western Blot Protocol Parameters for FBX14 Antibody

ParameterRecommended ConditionNotes
Primary Antibody Dilution1:500 to 1:2000Optimize based on specific lot and application
Blocking Solution5% non-fat milk or BSA in TBSTBSA may provide lower background for some applications
Primary Antibody IncubationOvernight at 4°CGentle agitation recommended
Washing3 × 10 minutes with TBSTThorough washing critical for reducing background
Secondary AntibodyAnti-rabbit IgG-HRP at 1:5000-1:10000Select based on detection system
Detection MethodEnhanced chemiluminescence (ECL)Exposure time determined empirically
Expected Band SizeBased on FBX14 molecular weightVerify against positive control

What controls should be included when using FBX14 antibody in experiments?

When conducting experiments with FBX14 antibody, several controls should be incorporated to ensure result validity and reliable interpretation. A positive control consisting of Arabidopsis thaliana wild-type tissue or recombinant FBX14 protein should be included to confirm antibody functionality and establish the correct band size. A negative control using FBX14 knockout or knockdown plant lines would provide validation of antibody specificity by demonstrating reduced or absent signal. Additionally, a secondary antibody-only control (omitting primary antibody) helps assess non-specific binding of the secondary antibody and establishes background signal levels. For more stringent validation, a blocking peptide competition assay can be performed, where pre-incubation of the antibody with excess FBX14 immunogenic peptide should abolish specific signals if the antibody is truly specific. When performing immunohistochemistry or immunofluorescence, additional controls should include omission of primary antibody and use of pre-immune serum to evaluate background and non-specific staining patterns.

How can FBX14 antibody be used to study protein-protein interactions in plant systems?

FBX14 antibody can be utilized in co-immunoprecipitation (Co-IP) experiments to identify and characterize protein-protein interactions involving FBX14 in plant systems. For this application, plant tissue lysates can be incubated with FBX14 antibody coupled to protein A/G beads, allowing precipitation of FBX14 along with its interacting partners. The precipitated complexes can then be analyzed by mass spectrometry or Western blotting to identify the components. For verification of specific interactions, researchers can perform reciprocal Co-IPs using antibodies against suspected interaction partners. Additionally, proximity ligation assays (PLA) using FBX14 antibody paired with antibodies against potential interacting proteins can provide in situ visualization of protein complexes in plant cells with high specificity and sensitivity. When studying dynamic interactions, researchers might consider combining FBX14 immunoprecipitation with crosslinking approaches to capture transient interactions, particularly important for F-box proteins which often have dynamic interactions with their substrates during the ubiquitination process. These methods collectively provide powerful tools for elucidating the functional networks and mechanisms through which FBX14 operates in plant cellular processes.

What approaches can be used to validate FBX14 antibody specificity for research applications?

Validating FBX14 antibody specificity is crucial for ensuring reliable research outcomes, particularly for less characterized antibodies. Western blot analysis using both wild-type and FBX14 knockout/knockdown plant lines represents the gold standard for validation, with the appearance of a specific band at the expected molecular weight in wild-type samples and reduced or absent signal in knockout samples confirming specificity. Mass spectrometry analysis of immunoprecipitated proteins can provide unbiased confirmation of antibody specificity by identifying peptides specific to FBX14. Researchers should also consider heterologous expression systems, where FBX14 can be expressed with epitope tags in systems like E. coli or plant protoplasts, allowing parallel detection with both the FBX14 antibody and tag-specific antibodies to confirm target recognition. Peptide competition assays provide another validation approach, where pre-incubation of the antibody with the immunizing peptide should block specific binding if the antibody is truly target-specific. For applications beyond Western blotting, such as immunohistochemistry or immunofluorescence, additional validation steps including signal localization consistent with known FBX14 distribution patterns should be performed to ensure application-specific reliability.

How can FBX14 antibody be used to study protein degradation pathways in plants?

As an antibody targeting an F-box protein involved in the ubiquitin-proteasome system, FBX14 antibody can be instrumental in studying protein degradation pathways in plants. Researchers can use the antibody in pulse-chase experiments combined with immunoprecipitation to track the turnover rates of FBX14 and its substrate proteins under various conditions or treatments. Cycloheximide chase assays utilizing FBX14 antibody for detection can reveal the half-life of FBX14 itself and how its stability may be regulated under different physiological conditions or stress responses. To identify specific substrates of FBX14-containing SCF complexes, researchers can employ strategies combining proteasome inhibitors (such as MG132) with FBX14 immunoprecipitation followed by mass spectrometry analysis, which can capture stabilized substrate proteins that would otherwise be rapidly degraded. Immunofluorescence approaches using FBX14 antibody can provide spatial information about where in the cell these degradation processes are occurring, potentially revealing compartment-specific roles for FBX14-mediated protein turnover. These approaches collectively enable detailed characterization of the regulatory mechanisms governing protein homeostasis in plant systems and the specific contribution of FBX14 to these essential cellular processes.

What are common problems encountered when using FBX14 antibody and how can they be addressed?

Researchers working with FBX14 antibody may encounter several common issues that can be systematically addressed through optimization strategies. High background signal in Western blots or immunostaining can result from insufficient blocking or excessive antibody concentration, and can be mitigated by increasing blocking time (to 2-3 hours), using alternative blocking reagents (switching between milk and BSA), or further diluting the primary antibody. Weak or absent signal might stem from protein degradation during sample preparation, inefficient protein transfer during Western blotting, or suboptimal antibody dilution, requiring adjustments to extraction protocols (adding more protease inhibitors), optimizing transfer conditions, or testing more concentrated antibody solutions. Multiple bands or non-specific signals may indicate cross-reactivity, which can be addressed by increasing the stringency of washing steps, optimizing antibody dilution, or using alternative extraction buffers to reduce interfering proteins. Batch-to-batch variation in antibody performance can significantly impact experimental reproducibility, necessitating careful validation of each new lot and maintenance of detailed records of optimal conditions for each batch. For particularly challenging applications, consideration of alternative detection methods such as more sensitive chemiluminescent substrates or signal amplification systems may be necessary to achieve desired results.

Table 2: Troubleshooting Guide for FBX14 Antibody Applications

IssuePossible CausesSolutions
High backgroundInsufficient blocking, antibody concentration too highIncrease blocking time/concentration, dilute antibody further
Weak/no signalProtein degradation, inefficient transfer, low antibody concentrationAdd protease inhibitors, optimize transfer, increase antibody concentration
Multiple bandsCross-reactivity, protein degradationIncrease wash stringency, add protease inhibitors, validate antibody
Inconsistent resultsBatch variation, sample handlingValidate each new antibody lot, standardize protocols
Non-specific bindingSecondary antibody issues, insufficient blockingTest secondary antibody alone, optimize blocking

How can FBX14 antibody performance be optimized for different plant tissues and developmental stages?

Optimizing FBX14 antibody performance across different plant tissues and developmental stages requires careful consideration of tissue-specific factors that may affect antibody binding and specificity. For tissues with high levels of phenolic compounds or secondary metabolites (such as mature leaves or roots), modified extraction buffers containing polyvinylpyrrolidone (PVP) or polyvinylpolypyrrolidone (PVPP) can help prevent interference with antibody binding. Tissues with different protein expression levels may require adjusted antibody dilutions; for tissues with expected low FBX14 expression, more concentrated antibody solutions and extended incubation times may be necessary. When working with difficult-to-extract tissues like seeds or siliques, researchers should consider enhanced mechanical disruption methods (such as bead-beating) combined with more stringent extraction buffers to ensure sufficient protein release for subsequent detection. For developmental studies, it's important to establish a baseline of FBX14 expression patterns across different stages using techniques like qRT-PCR alongside antibody-based detection to properly interpret changes in protein levels. Particularly for quantitative comparisons across developmental stages or tissues, researchers should establish and use consistent internal loading controls appropriate for the specific tissues being compared to ensure accurate normalization and interpretation of results.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.